期刊文献+

可溶性单链MHC-肽四聚体的构建研究 被引量:1

Preparing of the single-chain MHC-peptide complex tetramer
下载PDF
导出
摘要 目的:构建检测抗原特异性细胞毒性T淋巴细胞的单链MHC-肽四聚体。方法:通过在MHC重链基因中引入生物素化位点,并在轻链和重链基因中引入同一限制性酶切位点连接MHC轻链和重链构建可生物素化的单链MHC分子。结果:重组子以包涵体形式表达得到单链MHC分子,重折叠、生物素化、荧光标记后得到活性单链MHC-肽四聚体。结论:单链MHC分子操作简便,提高了四聚体构建效率。 Objective:To construct a single chain MHC-epitope tetramers for detecting epitope specific cytotoxic T lymphocyte. Motheds:The C terminus of β2m fusing with extracellular domains of HLA A0201 was connected with a accessional BirA substrate peptide by a linker through restriction enzyme digestion and hgation. Results:Expression of the recombinant in a pET systerm as inclusion body was followed by refolded in the presence of the antigenic peptide. After biotinylization of the MHC-peptide complex, the tetramers was obtained by the coupling of a fluorchrome conjugated streptavidin with the complex. Conclusion:The novel method of constitution of tetramers was more efficient than the old labor-consuming one.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2009年第3期328-332,共5页 Journal of Nanjing Medical University(Natural Sciences)
关键词 细胞毒性T淋巴细胞 四聚体 表位 重折叠 CTL tetramers epitope refold
  • 相关文献

参考文献16

  • 1夏海鸣,吴引伟,殷国庆,黄培林.乙型肝炎病毒X基因在肝细胞肝癌及慢性乙型肝炎肝细胞染色体上整合情况的对照研究[J].南京医科大学学报(自然科学版),2007,27(11):1252-1256. 被引量:1
  • 2Tang TJ, Kwekkeboom J, Laman JD, et al. The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection[JJ. J Viral Hepat,2003,10(3):159-167
  • 3Yokouchi H, Chamoto K, Wakita D, et al. Tetramer-blocking assay for defining antigen-spe cific cytotoxic T lymphocytes using peptide-MHC tetramer [J]. Cancer Sci, 2006,97(2) : 148-154
  • 4Denkberg G, Cohen C J, Segal D,et al. Recombinant human single-chain MHC-peptide complexes made from E. coli By in vitro refolding: functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens[J ]. Eur J Immunol, 2000,30(12) : 3522-3532
  • 5Mage MG, Lee L, Ribaudo RK. A recombinant, soluble, single-chain class I major histocompatibility complex molecule with biological activity [J]. Proc Nadl Acad Sci USA, 1992,89(22) : 10658-10662
  • 6于乐成,侯金林.人类白细胞抗原限制性乙型肝炎病毒特异性细胞毒性T淋巴细胞表位研究进展[J].中华肝脏病杂志,2005,13(10):797-800. 被引量:10
  • 7Harty JT,Tvinnereim AR,White DW. CD8^+ T cell effector mechanisms in resistance to infection [J]. Annu Rev Immunol, 2000, 18 : 275-308
  • 8Herrmann SH,Mescher MF. The requirements for antigen multivalency in class Ⅰ antigen recognition and triggering of primed precursor cytolytic T lymphocytes [J]. J Immunol, 1986,136(8) :2816-2825
  • 9Schneck J, Maloy WL,Coligan JE,et al. Inhibition of an allospecific T cell hybridoma by soluble class Ⅰ proteins and peptides: estimation of the affinity of a T cell receptor for MHC[J]. Cell, 1989,56( 1 ) :47-55
  • 10Arnold B, Dill O, Kublebeck G,et al. Alloreactive immune responses of transgenic mice expressing a foreign transplantation antigen in a soluble form [J]. Proc Natl Acad Sci USA, 1988,85 (7) : 2269-2273

二级参考文献26

  • 1张晓东,马宏涛,叶丽虹,东楠,史志蔚,沙丽,王洪辉.HBXIP基因对乙肝病毒X蛋白诱导细胞凋亡的影响[J].中国生物化学与分子生物学报,2005,21(3):403-407. 被引量:10
  • 2东楠,李楠,叶丽虹,张晓东.乙肝病毒X蛋白诱导肝癌细胞凋亡的信号转导途径[J].中国生物化学与分子生物学报,2005,21(6):822-826. 被引量:3
  • 3夏海鸣,吴引伟,殷国庆.乙型肝炎病毒在慢性乙型肝炎患者肝细胞染色体上的整合情况[J].江苏医药,2006,32(3):201-201. 被引量:3
  • 4陈海蔚,徐令清.乙肝病毒血清标志物、PreS1抗原检测与肝癌诊断的关系[J].实用预防医学,2006,13(3):752-753. 被引量:5
  • 5Webster G, Bertoletti A. Quantity and quality of virus-specific CD8 cell response: relevance to the design of a therapeutic vaccine for chronic HBV infection. Mol Immunol, 2001, 38: 467-473.
  • 6Thimme R, Chang KM, Pemberton J, et al. Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51. J Virol, 2001,75: 3984-3987.
  • 7Liu CJ, Kao JH, Shau WY, et al. Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: correlation with viral serotypes and clinical stages of liver disease. J Med Virol, 2002, 68:50-59.
  • 8Khakoo SI, Ling R, Scott I, et al. Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals. Gut, 2000, 47: 137-143.
  • 9Bertoletti A, Chisari FV, Perma A, et al. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein.J Virol, 1993, 67: 2376-2380.
  • 10Loirat D, Lemonnier FA, Michel ML. Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization. J Immunol, 2000, 165: 4748-4755.

共引文献9

同被引文献8

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部